A neuroimaging biomarker for striatal dysfunction in schizophrenia

Journal: Nature Medicine

Published: 2020-03-23

DOI: 10.1038/s41591-020-0793-8

Affiliations: 29

Authors: 40

Go to article
Institutions Share
Peking University Sixth Hospital, China 0.17
Institute of Automation (IA), CAS, China 0.15
University of Chinese Academy of Sciences (UCAS), China 0.09
First Affiliated Hospital, KMU, China 0.08
Xijing Hospital, China 0.08
Zhumadian City Psychiatric Hospital, China 0.08
CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), China 0.06
Guangzhou Brain Hospital, China 0.05
Renmin Hospital of Wuhan University/Hubei General Hospital, China 0.05
Xinxiang Medical University (XXMU), China 0.04
Henan Key Laboratory of Biological Psychiatry, XXMU, China 0.03
Shanxi University (SXU), China 0.03
King's College London (KCL), United Kingdom (UK) 0.01
MRC London Institute of Medical Sciences (LMS), United Kingdom (UK) 0.01
Melbourne Neuropsychiatry Centre (MNC), Australia 0.01
The University of Melbourne (UniMelb), Australia 0.01
Alan Turing Institute, United Kingdom (UK) 0.01
University of Cambridge, United Kingdom (UK) 0.01
Artificial Intelligence Research (AIR), CAS, China 0.01
Institute of Biophysics (IBP), CAS, China 0.01
Center for Life Sciences (CLS), PKU, China 0.01
Peking University (PKU), China 0.01
University of Electronic Science and Technology of China (UESTC), China 0
The University of Queensland (UQ), Australia 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER